TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease

The microglial receptors CD33 and TREM2 have been associated with risk for Alzheimer’s disease (AD). Here, we investigated crosstalk between CD33 and TREM2. We showed that knockout of CD33 attenuated amyloid beta (Aβ) pathology and improved cognition in 5xFAD mice, both of which were abrogated by ad...

Full description

Saved in:
Bibliographic Details
Published inNeuron (Cambridge, Mass.) Vol. 103; no. 5; pp. 820 - 835.e7
Main Authors Griciuc, Ana, Patel, Shaun, Federico, Anthony N., Choi, Se Hoon, Innes, Brendan J., Oram, Mary K., Cereghetti, Gea, McGinty, Danielle, Anselmo, Anthony, Sadreyev, Ruslan I., Hickman, Suzanne E., El Khoury, Joseph, Colonna, Marco, Tanzi, Rudolph E.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 04.09.2019
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0896-6273
1097-4199
1097-4199
DOI10.1016/j.neuron.2019.06.010

Cover

Loading…